NPC1L1 protein expression, a direct target of ezetimibe, was enhanced by hyperglycemia in cultured intestinal cells and mRNA expression of NPC1L1 was also increased in type 2 diabetes patients18,19. The gene discussed is NPC1L1; the disease is type 2 diabetes mellitus.